TO COMPARE THE EFFECT OF LASUNADI VATI AND AROGYAVARDHINI VATI IN MEDOROGA (DYSLIPIDEMIA)

COMPARATIVE CLINICAL STUDY OF LASUNADI VATI AND AROGYAVARDHINI VATI IN MEDOROGA (DYSLIPIDEMIA) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/07/113450

Enrollment

Registered

2026-07-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnoses and confirmed cases of Dyslipidemia fulfilling atleast one of the following criteria on the basis of NCEP ATP 3 Guidelines : Serum Total Cholestrol more than 200mg/dl-300mg/dl Serum Triglyceride more than 150mg/dl Serum LDL Cholestrol more than 130mg/dl Serum HDL Cholestrol less than 40 mg/dl in males and less than 50mg/dl in females . Patients possessing sign and symptoms of Medoroga

Exclusion criteria

Exclusion criteria: Patients having past history of Myocardial Infarction , unstable Angina or Stroke Tuberculosis, Un controlled Diabetes Mellitus and other complicated systemic disorder and any psychatric ilness Uncontrolled Hypertension , uncontrolled Hypothyroidism , Dyslipidemia due to drug e.g. Glucocorticoids and Diuretics Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Reduction in Chala-sphika-udara-stana Kshudrashwasa Atikshudha Atipipasa Alasy/Utsahani SwedadhikyaTimepoint: Day 30, Day 60	—

Secondary

Measure	Time frame
Reduction in: Serum Total Cholestrol Serum Triglyceride Serum LDL Cholestrol Improvement in: Serum HDL C holestrolTimepoint: Day 30, Day 60	—

Countries

India

Contacts

Public ContactDr Jyoti Arya

Patanajali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar Delhi Highway Uttarakhand

drjyotiarya@gmail.com9897942660

Outcome results